BioSpace News Archive

Deals

Merck Snaps Up Preclinical Neurodegenerative Asset in $576 Million Buy

Merck plunked down $576 million to acquire San Diego-based Calporta to gain access to preclinical TRPML1 agonists that are seen as potential treatments for neurodegenerative disorders such as Alzheimer’s or Parkinson’s.

November 13, 2019
·
2 min read
·
Alex Keown
Drug Development

Kiadis to Restructure Months After Acquiring CytoSen Therapeutics

The company will discontinue development of its lead T-cell asset, ATIR101, halt its ongoing Phase III trial and lay off half its staff.

November 13, 2019
·
2 min read
·
Alex Keown
BioForest

Weill Neurohub Will Promote Cross-Institutional Collaboration in Brain Trauma and Neurodegenerative Diseases

The Weill Family Foundation, University of California, Berkeley, University of California, San Francisco and the University of Washington launched the Weill Neurohub with a $106 million gift.

November 13, 2019
·
3 min read
·
Mark Terry
Is DNA the Data Storage of the Future?

DNA is structurally suited to storing information for extended periods of time, given its half-life of 521 years.

November 13, 2019
·
4 min read
·
David Kirk
Drug Development

GSK’s Nucala Hits the Mark in Phase III HES Trial, Setting Up Potential Approval

HES is a rare group of inflammatory disorders that affects approximately 20,000 people around the world.

November 13, 2019
·
2 min read
·
Alex Keown
Watson-Marlow Fluid Technology Group’s puresu single-use tube assemblies offer reliable, sterile, customisable solutions for bioprocessing

The expanded product range offers tailor-made solutions for customers with specific bioprocessing requirements

November 13, 2019
·
2 min read
Unknown Virus Discovered In Human Body

Researchers from Karl Landsteiner University of Health Sciences have uncovered a new form of a virus that infects bacteria

November 13, 2019
·
5 min read
First-of-its kind SOLIQUA® treatment launched in Singapore to benefit adults with uncontrolled type 2 diabetes

Administered once-daily, SOLIQUA® allows patients with uncontrolled type 2 diabetes take charge of their long-term health

November 13, 2019
·
8 min read
Business

MaxQ AI® Partners with Arterys to Further Expand Global Access to the Company’s Innovative Intracranial Hemorrhage (ICH) Detection Solutions

Radiologists and care providers around the world will have access to MaxQ AI’s ACCIPIO® ICH and Stroke Platform through Arterys’ cloud-native medical imaging platform.

November 13, 2019
·
4 min read
Lonza’s New eCHO™ Basal Medium and Feed Facilitates Late-Stage Cell Viability and a Consistent Yield of High Integrity Proteins

Results demonstrating the performance of the eCHO™ Medium will be presented at the 2019 PEGS Europe and Antibody Engineering and Therapeutics conferences

November 13, 2019
·
6 min read